The potential impact of clinical factors on blood-based biomarkers for Alzheimer's disease

被引：9
|
作者：
Pan, Fengfeng [1 ]
Lu, Yan [1 ]
Huang, Qi [2 ]
Xie, Fang [2 ]
Yang, Jingye [1 ]
Guo, Qihao [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp Affiliated 6, Sch Med, Dept Gerontol, Shanghai 200233, Peoples R China
[2] Fudan Univ, Huashan Hosp, PET Ctr, Shanghai 200233, Peoples R China
来源：
TRANSLATIONAL NEURODEGENERATION | 2023年 / 12卷 / 01期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1186/s40035-023-00371-z
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] The potential impact of clinical factors on blood-based biomarkers for Alzheimer’s disease
    Fengfeng Pan
    Yan Lu
    Qi Huang
    Fang Xie
    Jingye Yang
    Qihao Guo
    Translational Neurodegeneration, 12
  • [2] Blood-based biomarkers for Alzheimer's disease?
    Charlotte Harrison
    Nature Reviews Drug Discovery, 2014, 13 (5) : 336 - 336
  • [3] Blood-based biomarkers for Alzheimer's disease
    Leuzy, Antoine
    Mattsson-Carlgren, Niklas
    Palmqvist, Sebastian
    Janelidze, Shorena
    Dage, Jeffrey L.
    Hansson, Oskar
    EMBO MOLECULAR MEDICINE, 2022, 14 (01)
  • [4] Blood-based biomarkers for Alzheimer's disease
    Chohan, Priyanka
    Dashwood, Mark
    Theodoulou, George
    Reed, Hannah
    Kuruvilla, Tarun
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2022, 26 (04) : 10 - 14
  • [5] Blood-based biomarkers for Alzheimer's disease
    不详
    NEUROSCIENTIST, 2024, 30 (02): : 155 - 155
  • [6] Alzheimer's disease and blood-based biomarkers - potential contexts of use
    Zverova, Martina
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 1877 - 1882
  • [7] Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
    Teunissen, Charlotte E.
    Verberk, Inge M. W.
    Thijssen, Elisabeth H.
    Vermunt, Lisa
    Hansson, Oskar
    Zetterberg, Henrik
    van der Flier, Wiesje M.
    Mielke, Michelle M.
    Del Campo, Marta
    LANCET NEUROLOGY, 2022, 21 (01): : 66 - 77
  • [8] Recommendations for clinical implementation of blood-based biomarkers for Alzheimer's disease
    Mielke, Michelle M.
    Anderson, Matthew
    Ashford, J. Wesson
    Jeromin, Andreas
    Lin, Pei-Jung
    Rosen, Allyson
    Tyrone, Jamie
    Vandevrede, Lawren
    Willis, Deanna R.
    Hansson, Oskar
    Khachaturian, Ara S.
    Schindler, Suzanne E.
    Weiss, Joan
    Batrla, Richard
    Bozeat, Sasha
    Dwyer, John R.
    Holzapfel, Drew
    Jones, Daryl Rhys
    Murray, James F.
    Partrick, Katherine A.
    Scholler, Emily
    Vradenburg, George
    Young, Dylan
    Braunstein, Joel B.
    Burnham, Samantha C.
    de Oliveira, Fabricio Ferreira
    Hu, Yan Helen
    Mattke, Soeren
    Merali, Zul
    Monane, Mark
    Sabbagh, Marwan Noel
    Shobin, Eli
    Weiner, Michael
    Udeh-Momoh, Chinedu T.
    ALZHEIMERS & DEMENTIA, 2024, 20 (11) : 8216 - 8224
  • [9] Blood-based molecular biomarkers for Alzheimer’s disease
    Henrik Zetterberg
    Samantha C. Burnham
    Molecular Brain, 12
  • [10] The future of blood-based biomarkers for Alzheimer's disease
    Henriksen, Kim
    O'Bryant, Sid E.
    Hamper, Harald
    Trojanowski, John Q.
    Montine, Thomas J.
    Jeromin, Andreas
    Blennow, Kaj
    Lonneborg, Anders
    Wyss-Coray, Tony
    Soares, Holly
    Bazenet, Chantal
    Sjogren, Magnus
    Hu, William
    Lovestone, Simon
    Karsdal, Morten A.
    Weiner, Michael W.
    ALZHEIMERS & DEMENTIA, 2014, 10 (01) : 115 - 131
12345